Skip to main content
Clinical Trials/NCT00243919
NCT00243919
Completed
Phase 3

Locomotor Experience Applied Post Stroke (LEAPS) Trial

Duke University8 sites in 1 country408 target enrollmentApril 2006
ConditionsStroke

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Stroke
Sponsor
Duke University
Enrollment
408
Locations
8
Primary Endpoint
Percentage of Patients Who Successfully Improved Functional Level of Walking at 1 Year Post-stroke
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to compare two different treatments to improve walking after stroke (or post-stroke).

Detailed Description

The impact of stroke on walking is significant, with only 37 percent of stroke survivors able to walk after the first week after stroke (or post-stroke). Even among those who achieve independent ambulation, significant residual deficits persist in balance and gait speed with a 73 percent incidence of falls among individuals with mild to moderate impairment 6 months post-stroke. Body weight supported treadmill training is one therapeutic method for locomotor training that is rapidly being adopted into physical rehabilitation to improve walking after stroke. The purpose of this multi-center, randomized controlled study is to compare two different treatments to improve walking after stroke. The two treatments are: 1) a training program that includes use of a body weight support system and a treadmill to practice walking and 2) a physical therapist monitored exercise program to work on general conditioning and strengthening in the patient's home. In addition, investigators will determine the best time to provide training after a stroke and if the training is beneficial for mild, moderate, or severe cases of stroke. Four hundred subjects will be recruited from five facilities in Florida and California. Screening and subject recruitment will take place within 45 days post-stroke. All stroke patients will be screened to determine eligibility for the study. Eligible subjects will be followed for 2 months post-stroke. At that time, those who are eligible for enrollment and who consent to participate will undergo an exercise tolerance test and baseline assessment. Following this evaluation, participants will be randomized into one of three groups, according to the severity of their locomotor impairment: early locomotor, late locomotor, or early home exercise. The early locomotor training group will begin the locomotor training program immediately (2 months post stroke). The locomotor training program is an out-patient program of locomotor training for 36 sessions, 3 times per week, using a body weight support system and stepping on a treadmill. The late locomotor training group will begin locomotor training at 6 months post-stroke. Participants in the early home exercise group will receive a non-specific low intensity exercise program beginning immediately (2 months post stroke).

Registry
clinicaltrials.gov
Start Date
April 2006
End Date
June 2012
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \>/=18
  • Stroke within 45-days
  • Residual paresis in the lower extremity (fugl-meyer le motor score \< 34)
  • Ability to sit unsupported for 30 seconds
  • Ability to walk at least 10 feet with maximum 1 person assist
  • Ability to follow a three step command
  • Provision of informed consent
  • A self-selected 10 meter gait speed less than 0.8 m/s at the 2-month post-stroke assessment
  • Successful completion of an exercise tolerance test

Exclusion Criteria

  • Lived in nursing home prior to stroke
  • Unable to ambulate at least 150 feet prior to stroke, or experienced intermittent claudication while walking less than 200 meters
  • Serious cardiac conditions (history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living). Anyone meeting New York Heart Association criteria for Class 3 or Class 4 heart disease will be excluded
  • History of serious chronic obstructive pulmonary disease or oxygen dependence
  • Severe weight bearing pain
  • Preexisting neurological disorders such as Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), dementia, or previous stroke with residual neurological deficits
  • History of major head trauma
  • Lower extremity amputation
  • Non-healing ulcers on the lower extremity
  • Renal dialysis or end stage liver disease

Outcomes

Primary Outcomes

Percentage of Patients Who Successfully Improved Functional Level of Walking at 1 Year Post-stroke

Time Frame: 12 months post-stroke

Success: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.

Walking Speed: Measured During a 10-meter Walk

Time Frame: Baseline and 12 months post-stroke

Secondary Outcomes

  • 6 Month Outcome: Walking Speed: Measured During a 10-meter Walk(Baseline and 6 months post-stroke)
  • Stroke Impact Scale (SIS) - Mobility(Baseline, 6 months and 12 months post-stroke)
  • Fugl-Meyer Lower Extremity Score(Baseline, 6 months and 12 months post-stroke)
  • Stroke Impact Scale (SIS) - Participation(Baseline, 6 months and 12 months post-stroke)
  • Berg Balance Score(Baseline, 6 months and 12 months post-stroke)
  • 6 Minute Walking Distance (Meters)(Baseline, 6 months and 12 months post-stroke)
  • Percentage of Patients Who Successfully Improved Functional Level of Walking at 6 Months Post-stroke(Baseline and 6 months post-stroke)
  • Step Activity Monitor (SAM)- Median of Average Number of Steps Per Day(Baseline, 6 months and 12 months post-stroke)
  • Stroke Impact Scale (SIS) - Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL)(Baseline, 6 months and 12 months post-stroke)
  • Activities Specific Balance Confidence (ABC) Score(Baseline, 6 months and 12 months post-stroke)

Study Sites (8)

Loading locations...

Similar Trials